-
Mixed results for Lyme disease vaccine hit Valneva shares
-
Far-right French president no certainty despite rise of extremes
-
Trump tells AFP 'things are going very well' on Iran
-
Ukraine hits major Russian oil port near Finland
-
EU chief in Australia as trade talks enter 'last mile'
-
UK police probe attack on Jewish ambulances
-
Oil prices slide, European stocks rebound on Trump's Iran remarks
-
Trump announces 'very good' talks with Iran on ending war
-
Arsenal's White gets first England call-up since 2022
-
Greece train tragedy trial adjourned amid courtroom chaos
-
Tottenham face key call as relegation threat grows
-
German court rejects landmark climate case against BMW, Mercedes
-
Trump lifts Iran threat after 'very good' talks on ending war
-
Iran defies Trump Hormuz ultimatum with naval mine threat
-
African players in Europe: Awoniyi seals key win for lowly Forest
-
France ex-PM Lionel Jospin dies aged 88
-
Runway collision kills two pilots, shutters New York airport
-
Hodgkinson in 'shape of her life' with eye on Kratochvilova's record
-
Griezmann given go-ahead to talk with Orlando City
-
Stocks tumble, oil jumps on Trump's Iran ultimatum
-
Mideast war threatens energy crisis worse than 1970s oil shocks
-
Pilot, co-pilot killed in runway collision at New York airport
-
Asian stocks tumble, oil jumps on Trump's Iran ultimatum
-
Plane, fire truck collide on runway at New York's LaGuardia Airport
-
Russia's Max: The unencrypted super-app being forced on citizens
-
EU chief in Australia with eyes on trade deal
-
Asia champions Japan need 'different tools' to win World Cup - coach
-
Global economy under 'major threat' from Strait of Hormuz crisis: IEA chief
-
Planet trapped record heat in 2025: UN
-
Israel launches new strikes on Tehran as Iran takes aim at Gulf sites
-
German court to rule in climate case against automakers
-
France's leftists win mayoral elections in largest cities
-
Cuba restores power grid after latest blackout
-
Asian stocks tumble as Trump gives Iran 48-hour ultimatum
-
Wolves rally past Celtics, Nuggets sink Blazers
-
Middle East war to dominate Houston's 'Davos of Energy'
-
Korda sends Alcaraz to another early exit in Miami, Sabalenka advances
-
Kim holds off Korda charge to win LPGA Founders Cup
-
Slovenia liberal PM claims win over conservatives in tight vote
-
Trump orders immigration agents to airports amid crippling budget standoff
-
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
-
From Chat to Camera: Safer LGBTQ Dating in the Video Era
-
Iran awaits Trump threat to blow up power plants
-
Alcaraz eyes clay court season after early Miami exit
-
Real Madrid down Atletico in derby, leaders Barca edge Rayo
-
Korda sends Alcaraz to another early exit in Miami
-
Bordeaux-Begles hammer Toulouse in Dupont absence
-
Slovenia PM claims election win as results show neck and neck finish
-
England's Fitzpatrick birdies 18th to win PGA Valspar title
-
Man City's League Cup glory adds twist to title race
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
P.AbuBaker--SF-PST